Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-κB

David E. Joyce(Eli Lilly (United States)), Brian W. Grinnell(Eli Lilly (United States))
Critical Care Medicine
May 1, 2002
Cited by 191


Related Papers